$7.8 M

Orgenesis Revenue Q2, 2019
Orgenesis Gross profit (Q2, 2019)2.8 M
Orgenesis Gross profit margin (Q2, 2019), %36.4%
Orgenesis Net income (Q2, 2019)5.8 M
Orgenesis EBIT (Q2, 2019)5.3 M
Orgenesis Cash, 30-Jun-201916.1 M

Orgenesis Funding

Summary Metrics

Founding Date

2008

Orgenesis Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

3.0m6.4m10.1m18.7m

Revenue growth, %

115%

Cost of goods sold

3.9m7.7m6.8m10.8m

Gross profit

(906.0k)(1.3m)3.3m7.8m

Gross profit Margin, %

(30%)(20%)33%42%

R&D expense

1.1m2.2m2.5m6.5m

General and administrative expense

3.0m4.0m6.2m9.2m16.3m

Operating expense total

3.0m4.0m6.2m11.7m22.8m

Depreciation and amortization

1.2m1.6m1.6m1.9m

EBIT

4.6m7.2m11.3m11.2m14.7m

EBIT margin, %

242%176%111%79%

Pre tax profit

5.4m10.7m13.7m17.8m

Income tax expense

(900.0k)(1.5m)(1.3m)

Net Income

(5.5m)4.5m9.2m12.4m19.1m

Orgenesis Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

50.8k1.3m4.2m891.0k3.5m16.1m

Accounts Receivable

1.2m1.2m1.3m4.2m

Inventories

301.0k400.0k725.0k1.7m

Current Assets

97.7k2.2m8.2m4.2m7.3m30.3m

PP&E

12.9k13.0k4.3m4.6m5.1m11.9m

Goodwill

9.5m9.6m10.7m15.2m

Total Assets

114.2k2.2m38.7m33.5m39.9m75.4m

Accounts Payable

138.8k1.1m3.5m4.6m3.9m3.8m

Current Liabilities

986.4k4.7m16.5m14.6m16.9m17.1m

Non-Current Liabilities

1.2m7.3m8.3m5.2m5.5m

Total Liabilities

2.1m23.7m22.9m22.1m22.6m

Additional Paid-in Capital

8.6m13.2m14.2m41.6m55.3m88.1m

Retained Earnings

(16.2m)(20.6m)(29.8m)(44.1m)(62.4m)

Total Equity

(2.0m)10.6m14.1m28.6m

Financial Leverage

-0.1 x3.2 x2.8 x2.6 x

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

237.4k12.4k1.5m520.1k185.0k264.3k933.0474.0270.03.9m658.0k762.0k4.2m4.5m16.7m14.4m16.1m

Accounts Receivable

278.7k847.5k1.7k1.7k1.8k1.5m3.0m2.1m1.2m1.3m4.2m6.0m6.9m

Inventories

259.1k264.7k418.0413.0391.0614.0k904.0k965.0k881.0k1.2m1.7m2.0m2.2m

Current Assets

276.7k134.6k1.6m1.2m2.5m3.0m5.1k5.1k5.3k7.4m6.1m5.7m8.6m13.7m24.7m23.9m27.1m

PP&E

12.0k14.7k15.7k18.4k4.0m4.3m4.6k4.8k4.9k4.6m4.8m5.0m5.6m7.5m11.1m12.8m14.3m

Goodwill

9.9m10.1m9.8k10.1k10.0k9.6m10.0m10.7m11.0m10.5m15.6m15.0m15.1m

Total Assets

293.4k154.3k1.7m1.2m34.6m35.6m36.2k36.7k36.6k36.3m36.3m37.4m42.4m47.0m69.3m84.8m84.6m

Accounts Payable

170.8k191.5k237.0k524.3k2.4m2.8m2.9k4.2k4.3k4.1m3.5m3.7m3.8m2.4m3.0m5.5m6.8m

Short-term debt

1.4m1.5m

Current Liabilities

1.2m1.2m4.3m4.4m8.2m10.4m12.4k14.4k14.9k18.1m16.1m17.6m16.2m13.0m15.0m21.8m23.1m

Non-Current Liabilities

743.0k561.6k1.4m411.9k10.0m9.7m7.1k6.8k7.8k12.4m10.2m8.6m2.9m2.1m5.7m17.4m20.4m

Total Debt

1.4m1.5m

Total Liabilities

2.0m18.2m20.1m19.5k21.2k22.7k30.6m26.2m19.0m15.1m20.7m39.1m43.5m

Common Stock

5.6k5.6k11.011.011.012.0k12.0k12.0k

Additional Paid-in Capital

9.7m11.6m12.6m13.4m13.5m13.9m37.8k39.4k40.1k45.1m48.9m50.5m61.1m76.8m80.9m94.0m94.4m

Retained Earnings

(13.2m)(16.7m)(17.0m)(18.1m)(19.7m)(20.4k)(24.3k)(27.0k)(38.8m)(39.4m)(41.3m)(49.7m)(52.3m)(57.4m)(73.5m)(78.7m)

Total Equity

(1.7m)16.7k15.5k13.8k5.7m9.9m11.3m19.5m25.8m30.0m21.4m16.8m

Financial Leverage

-0.2 x2.2 x2.4 x2.6 x6.3 x3.7 x3.3 x2.2 x1.8 x2.3 x4 x5 x

Orgenesis Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(5.5m)(5.5m)(4.5m)(9.2m)(12.4m)

Depreciation and Amortization

3.3k1.2m1.6m

Accounts Receivable

(731.0k)(54.0k)

Inventories

301.0k

Accounts Payable

3.0k1.0m1.5m1.1m(933.0k)

Cash From Operating Activities

(2.0m)(1.4m)(2.7m)(3.8m)(3.8m)

Purchases of PP&E

(7.8k)(4.7k)(982.0k)(1.4m)(975.0k)

Cash From Investing Activities

(10.2k)2.5k(932.0k)(1.5m)(3.4m)

Cash From Financing Activities

2.1m2.7m6.7m2.1m8.4m

Orgenesis Ratios

USDY, 2019

Financial Leverage

5 x